Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/115230
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHeise, Niels Valentin-
dc.contributor.authorSchmidt, Antonia-
dc.contributor.authorSchüler, Jördis-Ann-
dc.contributor.authorCsuk, René-
dc.date.accessioned2024-03-07T11:52:52Z-
dc.date.available2024-03-07T11:52:52Z-
dc.date.issued2024-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/117185-
dc.identifier.urihttp://dx.doi.org/10.25673/115230-
dc.description.abstractThe reaction of dehydroabiethylamine (DHA) with isocyanides and formaldehyde produces varying products depending on the conditions employed. In a 4-component Ugi reaction using benzyl isocyanide, paraformaldehyde, and TMS-azide, the anticipated tetrazole is formed. Nevertheless, other isocyanides were unsuccessful in these conditions. Upon substituting paraformaldehyde with formalin and utilizing ultrasound instead, bis-tetrazole formation was obtained in a pseudo-7-component reaction. A bis-benzyl-substituted tetrazole 5 demonstrated significant AChE and BChE inhibition in Ellman's assays. Molecular modeling corroborated these results, with compound 5 identified as a mixed-type inhibitor for both enzymes.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subject.ddc540-
dc.titleDehydroabietylamine derived bistetrazoles from ultrasound-assisted pseudo-seven-component Ugi reactions act as efficient and selective inhibitors of cholinesteraseseng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleEuropean journal of medicinal chemistry reports-
local.bibliographicCitation.volume10-
local.bibliographicCitation.publishernameElsevier-
local.bibliographicCitation.publisherplaceAmsterdam-
local.bibliographicCitation.doi10.1016/j.ejmcr.2023.100124-
local.openaccesstrue-
dc.identifier.ppn1882901576-
cbs.publication.displayform2024-
local.bibliographicCitation.year2024-
cbs.sru.importDate2024-03-07T11:52:19Z-
local.bibliographicCitationEnthalten in European journal of medicinal chemistry reports - Amsterdam : Elsevier, 2021-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
1-s2.0-S2772417423000249-main.pdf2.91 MBAdobe PDFThumbnail
View/Open